Read our project results and deliverables below!

RiskGONE Newsletter #1

RiskGONE Newsletter #3

RiskGONE Newsletter #4

Risk Governance of Nanotechnology - NMBP-13 Common leaflet of projects RiskGONE, Nanorigo and Gov4Nano

RiskGONE flyer


RiskGONE posters from final project workshop

CIDETEC, Nanomedicine, Characterization, fate and in vitro dosimetry of ENMs - Main CIDETEC contributions on RiskGONE project: download here

ECOS - Environmental Coalition on Standards, Communication and Links to International Bodies: download here

LIST, ENMs Characterisation, in vitro dosimetry and environmental fate: download here

LIST, Activities in the framework of RiskGONE - H2020-NMBP-13-2018 science-based risk governance of nano-technology: download here

Malsch TechnoValuation, Ethical Impacts of (Not) Sharing Nanosafety Data: download here

NanoBioReal, Monitoring nanoparticle-induced oxidative stress using cyclic voltammetry: download here

NanoBioReal, Nanotoxicity testing using electrical impedance and cyclic voltammetry: download here

NILU, Main project activities and outcomes: download here

NovaMechanics Ltd., NanoConstruct: A toolbox for the digital reconstruction of Energy Minimized NanoParticles Powered by Enalos Cloud Platform: download here

NovaMechanics Ltd., RiskGONE Cloud Platform: download here

NovaMechanics Ltd., An In Vitro dosimetry dose application for the numerical transport of engineered nanomaterials: download here

Swansea University, Report on the proof-of-concept evaluation of SOPs for innovative in vitro models and mechanistically relevant assays for nanosafety human hazard assessment: download here

University of Bergen, Non-invasive methods and biological models for nanotoxicity assessment: download here


RiskGONE project Deliverables

Work Package 3

Deliverable 3.2. Draft guidelines regarding the quantification of lifecycle environmental and human health risk indicators

Deliverable 3.3.: Draft guidelines regarding the quantification of macro-economic benefits

Deliverable 3.4.: Draft guidelines regarding the correct implementation of risk transfer in insurance models.

Deliverable 3.5.: Draft guidelines on the societal acceptance of nanomaterials considering risk and benefit perception

Deliverable 3.6.: Draft guidelines on Identification of regulatory and ethical risk thresholds


Work Package 4 

Deliverable 4.2.: Consolidated pre-validated guidance document on hydrodynamic diameter and size distribution determination

Deliverable 4.3.: Consolidated pre-validated guidance document on the dispersibility of ENMs

Deliverable 4.4: Consolidated pre-validated guidance document on the determination of ENMs endotoxins content

Deliverable 4.5: Consolidated pre-validated guidance document on zeta potential determination

Deliverable 4.6: Consolidated pre-validated guidance document on nanoparticle counting

Deliverable 4.7: Consolidated pre-validated guidance document on effective density

Deliverable 4.9: Harmonised SOP for the resuspension of ENMs in biological media and in vitro dosimetry


Work Package 5

Deliverable 5.1: Report on the final harmonised SOPs used to propose amendments to the existing OECD TGs

Deliverable 5.5.: Report on the expert meeting AOP draft review


Work Package 6

Deliverable 6.4_v1: Report on (feedback on) initial DEB-based AOP for chronic ecotoxicity to ENMs (based on workshop)


Work Package 7

Deliverable 7.2.: Project website, house style, and social media profiles finalized

Deliverable 7.3.: Risk Governance of Nanomaterials: Analysis of Operating Practices of Existing Bodies Full report available upon request.